These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8163495)

  • 1. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.
    McDonnell DP; Goldman ME
    J Biol Chem; 1994 Apr; 269(16):11945-9. PubMed ID: 8163495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
    Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
    EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
    Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
    Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity.
    McDonnell DP; Shahbaz MM; Vegeto E; Goldman ME
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):425-32. PubMed ID: 8180103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.
    Vegeto E; Shahbaz MM; Wen DX; Goldman ME; O'Malley BW; McDonnell DP
    Mol Endocrinol; 1993 Oct; 7(10):1244-55. PubMed ID: 8264658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antihormone action.
    Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
    Sartorius CA; Tung L; Takimoto GS; Horwitz KB
    J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
    Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
    Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.
    Edwards DP; Weigel NL; Nordeen SK; Beck CA
    Breast Cancer Res Treat; 1993; 27(1-2):41-56. PubMed ID: 8260729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
    Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
    Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo.
    Truss M; Bartsch J; Beato M
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11333-7. PubMed ID: 7972059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a negative regulatory function for steroid receptors.
    McDonnell DP; Vegeto E; O'Malley BW
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10563-7. PubMed ID: 1438251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.
    Giangrande PH; Kimbrel EA; Edwards DP; McDonnell DP
    Mol Cell Biol; 2000 May; 20(9):3102-15. PubMed ID: 10757795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
    Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins.
    Wagner BL; Pollio G; Giangrande P; Webster JC; Breslin M; Mais DE; Cook CE; Vedeckis WV; Cidlowski JA; McDonnell DP
    Endocrinology; 1999 Mar; 140(3):1449-58. PubMed ID: 10067874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.